DK0783319T3 - Muramyl peptide compositions for inhibiting HIV replication - Google Patents

Muramyl peptide compositions for inhibiting HIV replication

Info

Publication number
DK0783319T3
DK0783319T3 DK95932794T DK95932794T DK0783319T3 DK 0783319 T3 DK0783319 T3 DK 0783319T3 DK 95932794 T DK95932794 T DK 95932794T DK 95932794 T DK95932794 T DK 95932794T DK 0783319 T3 DK0783319 T3 DK 0783319T3
Authority
DK
Denmark
Prior art keywords
inhibiting hiv
hiv replication
peptide compositions
muramyl peptide
replication
Prior art date
Application number
DK95932794T
Other languages
Danish (da)
Inventor
Georges Bahr
Original Assignee
Vacsyn Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vacsyn Sa filed Critical Vacsyn Sa
Application granted granted Critical
Publication of DK0783319T3 publication Critical patent/DK0783319T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The use of non-toxic muramyl peptides, particularly Murabutide and Murametide, to prepare drugs for inhibiting HIV replication in humans is disclosed. Said muramyl peptides are capable of up to 100 % inhibition of retroviral replication in primary host monocyte cultures.
DK95932794T 1994-09-26 1995-09-26 Muramyl peptide compositions for inhibiting HIV replication DK0783319T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9411460A FR2724845B1 (en) 1994-09-26 1994-09-26 MURAMYL PEPTIDES COMPOSITIONS CAPABLE OF INHIBITING UP TO 100% REPLICATION OF AN ACQUIRED IMMUNO DEFICIENCY VIRUS, SUCH AS HIV
PCT/FR1995/001239 WO1996009837A1 (en) 1994-09-26 1995-09-26 Muramyl peptide compositions for inhibiting hiv replication

Publications (1)

Publication Number Publication Date
DK0783319T3 true DK0783319T3 (en) 2003-09-15

Family

ID=9467271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95932794T DK0783319T3 (en) 1994-09-26 1995-09-26 Muramyl peptide compositions for inhibiting HIV replication

Country Status (11)

Country Link
EP (1) EP0783319B1 (en)
JP (1) JPH10506120A (en)
AT (1) ATE240114T1 (en)
AU (1) AU3569995A (en)
CA (1) CA2200993A1 (en)
DE (1) DE69530779T2 (en)
DK (1) DK0783319T3 (en)
ES (1) ES2197923T3 (en)
FR (1) FR2724845B1 (en)
PT (1) PT783319E (en)
WO (1) WO1996009837A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3006697A (en) * 1996-05-10 1997-12-05 Endorex Corporation Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines
FR2809106A1 (en) * 2000-05-17 2001-11-23 Istac New human Ro/SSA-like polypeptide, useful for treatment, prevention and diagnosis of e.g. autoimmune disease and viral infection, also related nucleic acid and antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692148B3 (en) * 1992-06-12 1994-08-19 Vacsyn France Sa Adjuvant composition of humoral and cell-mediated immunity which does not induce a response vis-à-vis auto-antigenic determinants.

Also Published As

Publication number Publication date
FR2724845A1 (en) 1996-03-29
ES2197923T3 (en) 2004-01-16
WO1996009837A1 (en) 1996-04-04
FR2724845B1 (en) 1997-01-17
DE69530779T2 (en) 2004-03-25
ATE240114T1 (en) 2003-05-15
PT783319E (en) 2003-09-30
CA2200993A1 (en) 1996-04-04
AU3569995A (en) 1996-04-19
EP0783319B1 (en) 2003-05-14
JPH10506120A (en) 1998-06-16
EP0783319A1 (en) 1997-07-16
DE69530779D1 (en) 2003-06-18

Similar Documents

Publication Publication Date Title
TR200001982T2 (en) Pharmaceutical shot-release oral dosage form.
DK0760848T3 (en) Lactobacillus strains of human origin, their compositions and their use
IT1287967B1 (en) PHARMACEUTICAL PREPARATIONS FOR LOCAL ANESTHETIC USE
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
AR053946A2 (en) ORIGINAL BACILLUS STEAROTHERMOPHILUS ALFA-AMYLASE VARIANT
BR9708632A (en) Calcilic compounds
HUP9901186A2 (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
TR199901571T2 (en) T�berk�lozun imm�noterapi te�hisi i�in bile�ikler ve y�ntemler.
NO985981D0 (en) Insulin preparations containing NaCl
DK0960127T3 (en) Isolated dimeric fibroblast activating protein alpha and uses thereof
DK289285D0 (en) THYMOPENTIN ANALOGUE
DK0921787T3 (en) Administration dose of H +, K + -ATPase inhibitors
RS49599B (en) Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation
ES2131528T3 (en) NEW POLYPEPTIDES AND THEIR USE.
ES2123156T3 (en) COMPOUNDS AND PROCEDURES FOR THE INHIBITION OF HIV AND SIMILAR VIRUSES.
BR9807523A (en) Quinoxalins in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS.
NO980296D0 (en) Improved therapeutic agents
TR199901190T2 (en) Methods and compositions for the delivery and synthesis of interferon-(alpha) nucleic acids.
DK482185A (en) PEPTIDES, THEIR PREPARATION AND USE AS MEDICINES
ES2105605T3 (en) TAQUIQUININE ANTAGONISTS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS.
DK0707473T3 (en) Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymer beads
DK0783319T3 (en) Muramyl peptide compositions for inhibiting HIV replication
MX9307203A (en) STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED.
ES2089286T3 (en) NEW 2-AMINO-5-CIANO-1,4-DIHIDROPIRIDINAS, PROCEDURE FOR ITS PREPARATION AND USE IN MEDICINES.